Clinical trial
NeuroFinance Human Stress Trial During Financial and Informational Volatility (NFHST)
NCT07622589 is registered in ClinicalTrials.gov with Truway Health, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NeuroFinance Human Stress Trial During Financial and Informational Volatility (NFHST)
- Lead sponsor
- Truway Health, Inc.
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- July 15, 2026
- Completion date
- June 30, 2029
- Enrollment
- 2,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anxiety, autonomic nervous system dysfunction, behavioral health, burnout syndrome, cognitive fatigue, emotional stress, financial stress, heart rate variability, insomnia, neurobehavioral manifestations, occupational stress, psychological stress, sleep disturbance